Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
European Journal of Medicinal Chemistry
|
April 20, 2001
5-HT(6) receptor antagonists: lead optimisation and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides
M Bös, A J Sleight, T Godel, et al.
Bioorganic & Medicinal Chemistry
|
February 12, 1998
O-methylasparvenone, a nitrogen-free serotonin antagonist
M Bös, R Canesso, N Inoue-Ohga, et al.
Molecular Pharmacology
|
September 9, 1998
The 5-hydroxytryptamine6 receptor-selective radioligand [3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum
F G Boess, C Riemer, M Bös, et al.
Neuropharmacology
|
August 8, 2001
A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze
M L Woolley, J C Bentley, A J Sleight, et al.
Pharmacology, Biochemistry, and Behavior
|
January 1, 1996
Pharmacologic evaluation of the discriminative stimulus of metachlorophenylpiperazine
A Bourson, D Wanner, R Wyler, et al.
British Journal of Pharmacology
|
July 1, 1998
Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-HT6 receptors
A J Sleight, F G Boess, M Bös, et al.
Psychopharmacology
|
October 8, 2008
Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task
M V King, C H Spicer, A J Sleight, et al.
Neuropharmacology
|
April 1, 1997
Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells
F G Boess, F J Monsma, C Carolo, et al.
Journal of Medicinal Chemistry
|
August 15, 1997
Novel agonists of 5HT2C receptors. Synthesis and biological evaluation of substituted 2-(indol-1-yl)-1-methylethylamines and 2-(indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved therapeutics for obsessive compulsive disorder
M Bös, F Jenck, J R Martin, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
January 1, 1989
The clinical utility of pharmacological agents that act at serotonin receptors
S J Peroutka, A J Sleight, B G McCarthy, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
European Journal of Medicinal Chemistry
|
April 20, 2001
5-HT(6) receptor antagonists: lead optimisation and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides
M Bös, A J Sleight, T Godel, et al.
Bioorganic & Medicinal Chemistry
|
February 12, 1998
O-methylasparvenone, a nitrogen-free serotonin antagonist
M Bös, R Canesso, N Inoue-Ohga, et al.
Molecular Pharmacology
|
September 9, 1998
The 5-hydroxytryptamine6 receptor-selective radioligand [3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum
F G Boess, C Riemer, M Bös, et al.
Neuropharmacology
|
August 8, 2001
A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze
M L Woolley, J C Bentley, A J Sleight, et al.
Pharmacology, Biochemistry, and Behavior
|
January 1, 1996
Pharmacologic evaluation of the discriminative stimulus of metachlorophenylpiperazine
A Bourson, D Wanner, R Wyler, et al.
British Journal of Pharmacology
|
July 1, 1998
Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-HT6 receptors
A J Sleight, F G Boess, M Bös, et al.
Psychopharmacology
|
October 8, 2008
Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task
M V King, C H Spicer, A J Sleight, et al.
Neuropharmacology
|
April 1, 1997
Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells
F G Boess, F J Monsma, C Carolo, et al.
Journal of Medicinal Chemistry
|
August 15, 1997
Novel agonists of 5HT2C receptors. Synthesis and biological evaluation of substituted 2-(indol-1-yl)-1-methylethylamines and 2-(indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved therapeutics for obsessive compulsive disorder
M Bös, F Jenck, J R Martin, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
January 1, 1989
The clinical utility of pharmacological agents that act at serotonin receptors
S J Peroutka, A J Sleight, B G McCarthy, et al.
Page
of 4